PPARγ: the Dominant Regulator Among PPARs in Dry Eye Lacrimal Gland and Diabetic Lacrimal Gland

Overview

Journal Int J Ophthalmol

Specialty Ophthalmology

Date 2020 Jun 23

PMID 32566495

Citations 7

Authors

Peng-Yue Mu

Chen-Chen Chu

Di Yu

Yan Shao

Shao-Zhen Zhao

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate the regulatory roles of the members of the peroxisome proliferator-activated receptor (PPAR) family in lacrimal gland dysfunction under conditions of desiccating stress or diabetes.

Methods: Quantitative polymerase chain reaction (qPCR) was used to examine the expression of PPARs in the cornea, conjunctiva, meibomian gland, and lacrimal gland in adult rats. The rats were divided into 3 groups: a control group, dry eye group, and diabetic group. The phenol red threads test, tear film break-up time (BUT) test and fluorescein staining were carried out to evaluate the development of dry eye. Based on bioinformatics research, qPCR was used to examine the expression level of PPARγ, tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), sirtuin 1 (Sirt1), myeloid differentiation factor 88 (MyD88) and transforming growth factor-β (TGF-β) in the lacrimal glands.

Results: PPARα and PPARβ/δ were mainly expressed in the conjunctiva and the lacrimal gland, respectively. However, PPARγ was expressed in both the conjunctiva and lacrimal gland, at much higher levels than those measured for PPARα and PPARβ/δ. Dry eye rats and diabetic rats both showed decreased tear secretion, shortened BUT, and increased corneal staining. Significant changes in gene expression were observed compared with the control group. In the lacrimal glands of dry eye rats and diabetic rats, expression of PPARγ decreased (<0.05), expression of Sirt1 also decreased (<0.01), whereas expression of TNF-α, IL-1β, IL-6, MyD88, and TGF-β increased (<0.05).

Conclusion: Among PPARs, PPARγ might play a dominant role in the regulation of metabolic- and inflammatory-signaling pathways on the ocular surfaces and in lacrimal glands. Down-regulation of PPARγ is highly relevant to lacrimal gland dysfunction under desiccating-stress and diabetic conditions. PPARγ, thus, is a potential therapeutic target in the treatment of environment- or diabetes-induced dry eye diseases.

Citing Articles

The role of PPAR in fungal keratitis.

Zhou H, Zhang H, Bi M, Zhang W Front Immunol. 2025; 15:1454463.

PMID: 39763659 PMC: 11700800. DOI: 10.3389/fimmu.2024.1454463.

Potential therapeutic effects of peroxisome proliferator-activated receptors on corneal diseases.

Chow B, Yu Lee I, Liu C, Liu Y Exp Biol Med (Maywood). 2024; 249:10142.

PMID: 38993197 PMC: 11238193. DOI: 10.3389/ebm.2024.10142.

Tear proteomics in dry eye disease.

Kannan R, Das S, Shetty R, Zhou L, Ghosh A, Deshpande V Indian J Ophthalmol. 2023; 71(4):1203-1214.

PMID: 37026251 PMC: 10276753. DOI: 10.4103/IJO.IJO_2851_22.

Changes in the meibomian glands in postmenopausal women with primary acquired nasolacrimal duct obstruction: a prospective study.

Jin H, Zhang H BMC Ophthalmol. 2023; 23(1):48.

PMID: 36726065 PMC: 9890874. DOI: 10.1186/s12886-023-02799-3.

Potential Mechanisms of White Peony against Primary Sjögren's Syndrome Based on Network Pharmacology and Molecular Docking.

Zhuang S, Pu J, Liang Y, Wu Z, Gao R, Pan S Evid Based Complement Alternat Med. 2022; 2022:5507472.

PMID: 35990826 PMC: 9391099. DOI: 10.1155/2022/5507472.

References

Zhang X, Zhao L, Deng S, Sun X, Wang N . Dry Eye Syndrome in Patients with Diabetes Mellitus: Prevalence, Etiology, and Clinical Characteristics. J Ophthalmol. 2016; 2016:8201053. PMC: 4861815. DOI: 10.1155/2016/8201053. View

Palomer X, Barroso E, Pizarro-Delgado J, Pena L, Botteri G, Zarei M . PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders. Int J Mol Sci. 2018; 19(3). PMC: 5877774. DOI: 10.3390/ijms19030913. View

Seifart U, Strempel I . [The dry eye and diabetes mellitus]. Ophthalmologe. 1994; 91(2):235-9. View

Tyagi S, Gupta P, Saini A, Kaushal C, Sharma S . The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases. J Adv Pharm Technol Res. 2012; 2(4):236-40. PMC: 3255347. DOI: 10.4103/2231-4040.90879. View

Clayton J . Dry Eye. N Engl J Med. 2018; 378(23):2212-2223. DOI: 10.1056/NEJMra1407936. View

Na K, Mok J, Kim J, Rho C, Joo C . Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest Ophthalmol Vis Sci. 2012; 53(9):5443-50. DOI: 10.1167/iovs.11-9417. View

Han S, Yang H, Hyon J . Influence of diabetes mellitus on anterior segment of the eye. Clin Interv Aging. 2019; 14:53-63. PMC: 6312050. DOI: 10.2147/CIA.S190713. View

Krauss A, Corrales R, Pelegrino F, Tukler-Henriksson J, Pflugfelder S, de Paiva C . Improvement of Outcome Measures of Dry Eye by a Novel Integrin Antagonist in the Murine Desiccating Stress Model. Invest Ophthalmol Vis Sci. 2015; 56(10):5888-95. PMC: 4566400. DOI: 10.1167/iovs.15-17249. View

Rocha E, Cunha D, Carneiro E, Boschero A, Saad M, Velloso L . Identification of insulin in the tear film and insulin receptor and IGF-1 receptor on the human ocular surface. Invest Ophthalmol Vis Sci. 2002; 43(4):963-7. View

10.

Hills C, Squires P . The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev. 2011; 22(3):131-9. DOI: 10.1016/j.cytogfr.2011.06.002. View

11.

Seo M, Kim J, Lee M, Sohn Y, Kang K, Yoo M . The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model. Curr Eye Res. 2010; 35(2):165-75. DOI: 10.3109/02713680903453494. View

12.

Conrady C, Joos Z, Patel B . Review: The Lacrimal Gland and Its Role in Dry Eye. J Ophthalmol. 2016; 2016:7542929. PMC: 4793137. DOI: 10.1155/2016/7542929. View

13.

Zhang H, You L, Zhao M . Rosiglitazone attenuates paraquat-induced lung fibrosis in rats in a PPAR gamma-dependent manner. Eur J Pharmacol. 2019; 851:133-143. DOI: 10.1016/j.ejphar.2019.02.037. View

14.

Bu J, Wu Y, Cai X, Jiang N, Jeyalatha M, Yu J . Hyperlipidemia induces meibomian gland dysfunction. Ocul Surf. 2019; 17(4):777-786. DOI: 10.1016/j.jtos.2019.06.002. View

15.

Szalardy L, Zadori D, Bencsik K, Vecsei L, Klivenyi P . Unlike PPARgamma, neither other PPARs nor PGC-1alpha is elevated in the cerebrospinal fluid of patients with multiple sclerosis. Neurosci Lett. 2017; 651:128-133. DOI: 10.1016/j.neulet.2017.05.008. View

16.

Kojima T . Contact Lens-Associated Dry Eye Disease: Recent Advances Worldwide and in Japan. Invest Ophthalmol Vis Sci. 2018; 59(14):DES102-DES108. DOI: 10.1167/iovs.17-23685. View

17.

Chen Y, Zhang X, Yang L, Li M, Li B, Wang W . Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice. Mol Med Rep. 2014; 9(5):2015-23. DOI: 10.3892/mmr.2014.2041. View

18.

Contreras-Ruiz L, Mir F, Turpie B, Krauss A, Masli S . Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090. Exp Eye Res. 2015; 143:1-8. DOI: 10.1016/j.exer.2015.10.008. View

19.

Pham J, Arul Nambi Rajan K, Li P, Parast M . The role of Sirtuin1-PPARγ axis in placental development and function. J Mol Endocrinol. 2018; 60(4):R201-R212. PMC: 8584848. DOI: 10.1530/JME-17-0315. View

20.

Yue Y, Meng K, Pu Y, Zhang X . Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy. Diabetes Res Clin Pract. 2017; 133:124-130. DOI: 10.1016/j.diabres.2017.08.018. View